Company Description

Endomedix is developing PLEXimine™ – a breakthrough technology poised to transform biosurgery and other medical applications. A new technology platform, based on precision polysaccharide chemistry, that gives surgeons the ability to form dynamic, structured medical devices in situ, enhancing care in established and new procedures.